Skip to content
The Policy VaultThe Policy Vault

doxepinCareFirst (Caremark)

anxiety

Preferred products

  • desipramine (Norpramin)
  • nortriptyline (Pamelor)

Initial criteria

  • Patient age ≥ 65 years
  • Diagnosis of depression and/or anxiety
  • Patient has experienced inadequate treatment response or intolerance to at least TWO of the following agents: a serotonin-norepinephrine reuptake inhibitor (SNRI), a selective serotonin reuptake inhibitor (SSRI), mirtazapine, bupropion, trazodone
  • Patient has experienced an inadequate treatment response or intolerance to a trial of desipramine (Norpramin) or nortriptyline (Pamelor)